Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Consolidated Statements of Operations and Comprehensive Loss
Revenue	$ 20,139	$ 17,410
Operating Expenses
Direct costs	20,284	27,731
Research and development	73,341	54,749
Selling, general and administrative	31,847	25,550
Total operating expenses	125,472	108,030
Operating Loss	(105,333)	(90,620)
Nonoperating Income and Expense
Interest income	17,671	20,265
Change in fair value of warrant liabilities	(4,508)	4,890
Interest expense	(46)	(84)
Other expense	(2,977)
Total nonoperating income and expense	10,140	25,071
Pretax Loss	(95,193)	(65,549)
Income tax expense	1,194
Share of net loss of equity method investee	133
Net Loss Attributable to Common Stockholders	(96,520)	(65,549)
Other Comprehensive Income	598	2,600
Comprehensive Loss Attributable to Common Stockholders	$ (95,922)	$ (62,949)
Basic loss per share	$ (0.54)	$ (0.37)
Diluted loss per share	$ (0.54)	$ (0.37)
Weighted average shares outstanding - Basic	179,397,332	178,006,919
Weighted average shares outstanding - Diluted	179,397,332	178,006,919